SMC
CDC icon

Smith, Moore & Co’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Smith, Moore & Co’s Portfolio CDC Stock Details CDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,870
Closed -$332K – 431
2023
Q4 		$332K Sell
5,870
-142,468
-96% -$7.96M 0.04% 315
2023
Q3 		$8.29M Sell
148,338
-23,732
-14% -$1.35M 1.09% 18
2023
Q2 		$9.91M Sell
172,070
-420
-0.2% -$24.7K 1.26% 17
2023
Q1 		$10.5M Sell
172,490
-13,660
-7% -$855K 1.42% 16
2022
Q4 		$11.6M Sell
186,150
-433
-0.2% -$27.1K 1.6% 15
2022
Q3 		$11.1M Sell
186,583
-86,138
-32% -$5.72M 1.68% 13
2022
Q2 		$18M Buy
272,721
+133,596
+96% +$9.34M 2.78% 8
2022
Q1 		$10M Buy
139,125
+132,285
+1,934% +$9.27M 1.36% 14
2021
Q4 		$476K Buy
6,840
+16
+0.2% +$1.07K 0.07% 243
2021
Q3 		$439K Buy
6,824
+11
+0.2% +$721 0.07% 246
2021
Q2 		$440K Buy
6,813
+10
+0.1% +$651 0.07% 250
2021
Q1 		$424K Buy
6,803
+6
+0.1% +$346 0.07% 248
2020
Q4 		$366K Sell
6,797
-885
-12% -$45.3K 0.07% 234
2020
Q3 		$364K Sell
7,682
-95,840
-93% -$4.57M 0.08% 230
2020
Q2 		$4.82M Buy
103,522
+307
+0.3% +$14K 1.06% 19
2020
Q1 		$4.27M Buy
103,215
+2,248
+2% +$103K 1.13% 19
2019
Q4 		$4.95M Sell
100,967
-145
-0.1% -$6.87K 1.03% 20
2019
Q3 		$4.71M Buy
101,112
+1,674
+2% +$76.1K 1.04% 21
2019
Q2 		$4.53M Buy
99,438
+4,635
+5% +$208K 1.02% 22
2019
Q1 		$4.22M Buy
+94,803
New +$4.14M 1% 21

Other funds holding CDC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Smith, Moore & Co's CDC Position: Q1 2024 in Review

Smith, Moore & Co sold out of VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) in Q1 2024, closing a stake of 5,870 shares — an estimated $332K sold.

Smith, Moore & Co first reported a position in CDC in Q1 2019 and held it in 20 quarters. The position peaked at $18M in Q2 2022. 104 funds tracked by Wall St. Rank hold CDC as of Q1 2024.

  • Smith, Moore & Co reported no remaining VictoryShares US EQ Income Enhanced Volatility Wtd ETF position as of Q1 2024 after selling out during the quarter.
  • Smith, Moore & Co sold 5,870 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q1 2024, an estimated $332K.
  • Smith, Moore & Co first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q1 2019 and held it in 20 quarters.
  • Smith, Moore & Co's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $18M in Q2 2022.
  • 104 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q1 2024.

Based on Smith, Moore & Co's 13F filing for Q1 2024, filed 13 May 2024.